Vela Minerals Aktie - VLA

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

0,145

Gebot

0,145

Fragen

0,18

Volumen

0,00 Tagesbereich 0,00

0,145 52-Wochen-Bereich 0,145

Marktkapitalisierung

9,219M

Handelsende

0,145

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

Ausgegebene Aktien

63.579.000

Dividendenrendite

Kurs-Gewinn-Verhältnis

-21,54

Gewinn pro Aktie (EPS)

-0,01

Erlöse

Nettogewinn

-411k

Sektor

Miscellaneous Metal Ores,nec

Branche

Miscellaneous Metal Ores,nec

Website

www.arbormetalscorp.com

Hauptsitz

Vancouver, British Columbia, Can

Gegründet

Vela Minerals Ltd is listed in the Miscellaneous Metal Ores sector of the TSX Venture Börse with ticker VLA. The last closing price for Vela Minerals was $0,15. Over the last year, Vela Minerals shares have traded in a share price range of $ 0,145 to $ 0,145.

Vela Minerals currently has 63.579.000 shares in issue. The market capitalisation of Vela Minerals is $9,22 million. Vela Minerals has a price to earnings ratio (PE ratio) of -21.54.

Valneva and VBI Vaccines Announce European Partnership for Marketing and Distribution of PreHevbri®

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) (Valneva) and VBI Vaccines Inc. (Nasdaq: VBIV) (VBI) today announced a partnership in select...

Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15

Approximately 6,000 participants 5 years of age and older will be enrolled in Lyme disease-endemic regions in Europe and the U.S. Pfizer Inc...

Valneva and Pfizer Enter into an Equity Subscription Agreement and Update Terms of Collaboration Agreement for Lyme Disease Vaccine Candidate VLA15

Pfizer will invest €90.5 million in Valneva Planned Phase 3 study confirmed to initiate in Q3 2022 Valneva SE (Nasdaq: VALN; Euronext Paris:...

VALNEVA Reports Strong Business Performance in First Nine Months. Company Raises Financial Guidance for FY 2016

Lyon, France, Nov. 09, 2016 (GLOBE NEWSWIRE) -- Valneva Reports Strong Business Performance in First Nine Months Company Increases...

VALNEVA Announces Approval of an EB66(R)-based Prototype Influenza Vaccine in Japan

LYON, France, March 26, 2015 (GLOBE NEWSWIRE) -- The vaccine was developed by the Chemo-Sero Therapeutic Research Institute (Kaketsuken) in...

VALNEVA Reports Annual Results 2014: the company announces a significant improvement to its EBITDA and a strong reduction of ...

LYON, France, March 20, 2015 (GLOBE NEWSWIRE) -- Valneva Reports Annual Results 2014 The company announces a significant improvement to its...

VALNEVA announces signing of an exclusive license agreement on EB66(r) Cell Line for Human and Veterinary Vaccines in China

LYON, France, March 17, 2015 (GLOBE NEWSWIRE) -- Valneva announces signing of an exclusive license agreement on EB66® Cell Line for Human...

AMAG Pharmaceuticals Announces Appointment of Jim Sulat to Its Board of Directors and the Transition of Chairman Role to Gino...

WALTHAM, Mass., April 16, 2014 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced...

Zeitraum †	Handelsbeginn	Hoch	Niedrig
1	0.145	0.145	0.145	CS
4	0.145	0.145	0.145	CS
12	0.145	0.145	0.145	CS
26	0.145	0.145	0.145	CS
52	0.145	0.145	0.145	CS
156	0.145	0.145	0.145	CS
260	0.145	0.145	0.145	CS

VLA - Frequently Asked Questions (FAQ)

What is the current Vela Minerals share price?

The current share price of Vela Minerals is $ 0,145

How many Vela Minerals shares are in issue?

Vela Minerals has 63.579.000 shares in issue

What is the market cap of Vela Minerals?

The market capitalisation of Vela Minerals is CAD 9,22M

What is the 1 year trading range for Vela Minerals share price?

Vela Minerals has traded in the range of $ 0,145 to $ 0,145 during the past year

What is the PE ratio of Vela Minerals?

The price to earnings ratio of Vela Minerals is -21,54

What is the reporting currency for Vela Minerals?

Vela Minerals reports financial results in CAD

What is the latest annual profit for Vela Minerals?

The latest annual profit of Vela Minerals is CAD -411k

What is the registered address of Vela Minerals?

The registered address for Vela Minerals is 2200 - 885 WEST GEORGIA STREET, VANCOUVER, BRITISH COLUMBIA, V6C 3G1

What is the Vela Minerals website address?

The website address for Vela Minerals is www.arbormetalscorp.com

Which industry sector does Vela Minerals operate in?

Vela Minerals operates in the MISCELLANEOUS METAL ORES,NEC sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
YVR.PBadger Capital Corp	$ 0,15 (114,29%)	1.000
MPTH.HMapath Capital Corp	$ 0,03 (100,00%)	1.000
CPLCopper Lake Resources Ltd	$ 0,01 (100,00%)	4,56k
NIKL.HGK Resources LTD	$ 0,085 (88,89%)	2k
AAA.PFirst Tidal Acquisition Corp	$ 0,10 (81,82%)	7k
HCM.HHighcliff Metals Inc	$ 0,02 (-80,00%)	1,33k
RUN.HRunning Fox Resource Corp	$ 0,005 (-50,00%)	1.000
PONDPond Technologies Holdings Inc	$ 0,005 (-50,00%)	3,5k
MAHMarksmen Energy Inc	$ 0,005 (-50,00%)	90k
TRSTresOr Resources Ltd	$ 0,06 (-36,84%)	5k
JUGRJuggernaut Exploration Ltd	$ 0,075 (7,14%)	2,14M
FKMFokus Mining Corporation	$ 0,13 (8,33%)	1,36M
OMOsisko Metals Incorporated	$ 0,455 (5,81%)	1,34M
ATYAtico Mining Corp	$ 0,06 (33,33%)	1,25M
AMKAmerican Creek Resources Ltd	$ 0,10 (5,26%)	1,24M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Vela Minerals Ltd (VLA)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Über Vela Minerals Ltd

VLA Neueste Nachrichten

Valneva and VBI Vaccines Announce European Partnership for Marketing and Distribution of PreHevbri®

Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15

Valneva and Pfizer Enter into an Equity Subscription Agreement and Update Terms of Collaboration Agreement for Lyme Disease Vaccine Candidate VLA15

VALNEVA Reports Strong Business Performance in First Nine Months. Company Raises Financial Guidance for FY 2016

VALNEVA Announces Approval of an EB66(R)-based Prototype Influenza Vaccine in Japan

VALNEVA Reports Annual Results 2014: the company announces a significant improvement to its EBITDA and a strong reduction of ...

VALNEVA announces signing of an exclusive license agreement on EB66(r) Cell Line for Human and Veterinary Vaccines in China

AMAG Pharmaceuticals Announces Appointment of Jim Sulat to Its Board of Directors and the Transition of Chairman Role to Gino...

VLA - Frequently Asked Questions (FAQ)

Beweger

VLA Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Vela Minerals Ltd (VLA) Börsenkurse

Vela Minerals Ltd (VLA)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Über Vela Minerals Ltd

VLA Neueste Nachrichten

Valneva and VBI Vaccines Announce European Partnership for Marketing and Distribution of PreHevbri®

Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15

Valneva and Pfizer Enter into an Equity Subscription Agreement and Update Terms of Collaboration Agreement for Lyme Disease Vaccine Candidate VLA15

VALNEVA Reports Strong Business Performance in First Nine Months. Company Raises Financial Guidance for FY 2016

VALNEVA Announces Approval of an EB66(R)-based Prototype Influenza Vaccine in Japan

VALNEVA Reports Annual Results 2014: the company announces a significant improvement to its EBITDA and a strong reduction of ...

VALNEVA announces signing of an exclusive license agreement on EB66(r) Cell Line for Human and Veterinary Vaccines in China

AMAG Pharmaceuticals Announces Appointment of Jim Sulat to Its Board of Directors and the Transition of Chairman Role to Gino...

VLA - Frequently Asked Questions (FAQ)

Beweger

VLA Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen